2017 Apr 18
Obinutuzumab vs. rituximab weighed as follicular lymphoma therapy
John Leonard, M.D., discusses the optimal follicular lymphoma treatment. Read more
2017 Apr 17
New study challenges diagnostic approach for common urological condition
Combining kidney ultrasound with a visual examination of the bladder and urethra appears to be the most cost-effective way to screen for cancers of the genitourinary tract in people with microscopic amounts of blood in their urine, according to Weill Cornell urologists Read more
2017 Apr 14
Expanded drug combinations produce best myeloma induction
Ruben Niesvizky, M.D., discusses the optimal induction therapy for patients with multiple myeloma. Read more
2017 Apr 11
The federal panel that opposed prostate cancer screening just changed its mind
Jim Hu, M.D., comments on new PSA screening guidelines issued by the U.S. Preventive Services Task Force Read more
2017 Apr 07
Giving terminally ill patients the 'Right-to-Try'
Manish Shah, M.D., weighs in on proposed 'right-to-try" legislation that would give terminally ill patients access to experimental drugs. Read more
2017 Apr 06
We Are Weill Cornell Medicine: Dr. Praveen Raju
Praveen Raju, M.D., is a featured faculty member in the #WeAreWCM campaign. Read more
2017 Apr 05
In 2030, the top cancer in HIV patients may be a surprise
Ethel Cesarman, M.D., Ph.D., comments on a study about cancers linked to AIDS and suppressed immunity. Read more
2017 Apr 05
Indications of Early-Onset CRC
Manish A. Shah, M.D., discusses his research into indications of early-onset colorectal cancer. Read more
2017 Apr 05
Evolving therapeutic strategies in renal cell carcinoma
David Nanus, M.D., discusses evolving therapeutic strategies in the neoadjuvant and adjuvant setting for patients with RCC at the 2017 Interdisciplinary Prostate Cancer Congress. Read more
2017 Apr 05
Long-term aspirin may cut risk for cancer death
Manish Shah, M.D., comments on a study about the association of long-term aspirin use and cancer death. Read more
2017 Apr 03
Weill Cornell Medicine joins colorectal cancer 'Dream Team'
A $12 million award from the Stand Up to Cancer Foundation will help fund trials testing Vitamin C as a therapy for patients with colon, lung and pancreatic cancers. Read more
2017 Apr 02
Bringing bladder cancer into focus
Bishoy Faltas, M.D., and LaMont Barlow, M.D., are exploring FAK inhibition as a potential targeted therapy for urothelial cancer. Read more
2017 Apr 02
Cell therapy provides shot at a cure for fatal thyroid cancer
In the first demonstration of the potential for CAR-T therapy for previously untreatable advanced thyroid cancers, researchers from the Meyer Cancer Center were able to eliminate cancerous cells in cultures and mice. Read more
2017 Apr 01
Women with healthy BMI may have increased risk of breast cancer
Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to Andrew Dannenberg, M.D. Read more
2017 Apr 01
Toxic targets: Saving lives in silico
A computational tool created by graduate students predicts how people’s livers, hearts and other tissues might respond to different drugs, in order to ID potentially dangerous side effects before the drugs are tested in people. Read more
2017 Mar 31
Shedding a light on "dark matter" data
Ekta Khurana, Ph. D., assistant professor of computational genomics has created a computational tool that can mine terabytes of overlooked genomic data to uncover potentially unknown drivers of cancer. Read more
2017 Mar 30
Health conditions that disproportionately affect black women
Adrienne Phillips, M.D., discusses some cancers and blood disorders that are prevalent in black women. Read more
2017 Mar 23
Study to focus on breast cancer link to bone metastasis
Ithaca associate Claudia Fischbach-Teschl, Ph.D., has secured more than $1 million in funding from the Human Frontier Science Program (HFSP) to study breast cancer’s effect on the mineralization pathways in bone. Read more
2017 Mar 22
Why Trump’s N.I.H. cuts should worry us
A substantial N.I.H. budget cut would undermine the fiscal stability of universities and medical schools, many of which depend on N.I.H. funding; it would erode America’s leadership in medical research; and it would diminish opportunities to discover new ways to prevent and treat diseases, argues Harold Varmus, M.D. Read more
2017 Mar 22
Three-pronged approach key to precision medicine
Patient-derived organoids are allowing researchers and clinicians to take precision medicine to the next level, according to a new paper by Mark Rubin and Lewis Cantley. Read more
